erythromycin has been researched along with Lung Neoplasms in 24 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (16.67) | 18.7374 |
1990's | 8 (33.33) | 18.2507 |
2000's | 11 (45.83) | 29.6817 |
2010's | 1 (4.17) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gao, M; Li, C; Li, T; Li, Y; Qi, Q; Wang, A; Wang, B; Xu, L; Zhang, Y | 1 |
Barletta, E; Cusano, F; Ferrara, G; Ingordo, V | 1 |
Sugiyama, Y | 1 |
Fujiwara, Y; Fukui, S; Ito, T; Izumiyama, N; Kashima, M; Miura, H; Sano, M; Sasaki, M | 1 |
Aikawa, A; Date, J; Hashizume, M; Kato, K; Kidokoro, T; Kimura, B; Takano, T; Takaoka, K; Tokimitsu, S; Yamagishi, M | 1 |
Mikasa, K | 1 |
Boonstra, A; Kummer, JA; Susanto, CR; Vonk-Noordegraaf, A | 1 |
Akamine, S; Kabahara, R; Mochinaga, H; Morino, S; Muraoka, M; Tsuchiya, S; Uchiyama, Y; Yamaoka, N | 1 |
Dall, L; Martin, ML | 1 |
Brun, Y; Brune, J; Fleurette, J; Forey, F; Gamondes, JP; Tebib, A | 1 |
Fujii, T; Kitamura, S; Suga, T; Sugiyama, Y | 1 |
Jamal, SA; Murphy, GF; Siu, LL; Skorecki, KL; Tobe, SW; Warner, E | 1 |
Hamada, K; Kita, E; Mikasa, K; Narita, N; Sakamoto, M; Sawaki, M; Teramoto, S | 1 |
Goto, G; Ieshiro, R; Iguchi, M; Okamura, J; Ota, T; Yuasa, K | 1 |
Furunishi, M; Kita, E; Maeda, K; Mashima, T; Mikasa, K; Narita, N; Sakamoto, M; Ueta, K | 1 |
Kitada, H; Konishi, Y; Murakawa, K; Sakitani, H; Sasaki, Y; Shiraiwa, K; Takahama, M; Tsujiuchi, T; Tsutsumi, M; Yoshimoto, M | 1 |
Kita, E; Konishi, M; Maeda, K; Majima, T; Mikasa, K; Murakawa, K; Narita, N; Sakamoto, M; Takahashi, K; Yoshimoto, E | 1 |
Hiyama, K; Ishioka, S; Jougasaki, Y; Maeda, A; Maeda, H; Nishisaka, T; Yamakido, M; Yokozaki, M | 1 |
Fujiwara, Y; Fukui, S; Ito, T; Izumiyama, N; Kashima, M; Miura, M; Sano, M; Sasaki, M; Watanabe, A | 1 |
De Souza, A; Jones, JA; Morgan, WE; Morris, DL | 1 |
Kudo, S | 1 |
Friedman, GD; Selby, JV | 1 |
Fireman, BH; Friedman, GD; Selby, JV | 1 |
Ambrogi, V; Cristino, B; Mineo, TC; Reggio, S | 1 |
2 review(s) available for erythromycin and Lung Neoplasms
Article | Year |
---|---|
[Contribution of Japanese researchers to progress in the field of pulmonary medicine in the last 100 years: New pharmacological action of macrolides].
Topics: Anti-Bacterial Agents; Azithromycin; Bronchiolitis; Chronic Disease; Clarithromycin; Erythromycin; History, 20th Century; Humans; Japan; Lung Neoplasms; Respiratory Tract Infections | 2002 |
[Clinical application of the new action of macrolide preparations to respiratory diseases].
Topics: Anti-Bacterial Agents; Bacterial Infections; Bronchiectasis; Bronchitis; Chronic Disease; Clarithromycin; Erythromycin; Humans; Immunologic Factors; Lung Neoplasms | 1999 |
5 trial(s) available for erythromycin and Lung Neoplasms
Article | Year |
---|---|
Intrapleural combination therapy with lobaplatin and erythromycin for non-small cell lung cancer-mediated malignant pleural effusion.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Cyclobutanes; Erythromycin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Pleural Effusion, Malignant; Prospective Studies; Survival Analysis; Treatment Outcome | 2018 |
Vinblastine and erythromycin: an unrecognized serious drug interaction.
Topics: Aged; Carcinoma, Renal Cell; Constipation; Cyclosporine; Drug Synergism; Drug Therapy, Combination; Erythromycin; Humans; Kidney Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Muscle Spasticity; Neutropenia; Pain; Vinblastine | 1995 |
[Lung cancer: progress in diagnosis and treatment. IV. Related topics: 2. Macrolides as biological response modifiers for the treatment of lung cancer].
Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Carcinoma, Non-Small-Cell Lung; Clarithromycin; Erythromycin; Female; Humans; Immunologic Factors; Lung Neoplasms; Male; Mice; Middle Aged | 1997 |
[Usefulness of clarithromycin in paitents with unresectable non-small-cell lung cancer--clinical evaluation of those who survived for a long time and those succumbed in a short period].
Topics: Adenocarcinoma; Aged; Anti-Bacterial Agents; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Erythromycin; Female; Humans; Immunologic Factors; Lung Neoplasms; Male; Retrospective Studies | 2000 |
High and prolonged pulmonary tissue concentrations of azithromycin following a single oral dose.
Topics: Administration, Oral; Adult; Aged; Azithromycin; Biological Assay; Carcinoma, Bronchogenic; Chromatography, High Pressure Liquid; Drug Administration Schedule; Erythromycin; Humans; Lung; Lung Neoplasms; Middle Aged | 1991 |
17 other study(ies) available for erythromycin and Lung Neoplasms
Article | Year |
---|---|
Erlotinib-induced pustular eruption.
Topics: Acneiform Eruptions; Administration, Cutaneous; Anti-Bacterial Agents; Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Erythromycin; Gels; Humans; Lung Neoplasms; Male; Middle Aged; Protein Kinase Inhibitors; Quinazolines; Treatment Outcome | 2009 |
[Effect of 14-membered ring macrolides on heparanase mRNA expression in lung cancer cells].
Topics: Anti-Bacterial Agents; Cell Movement; Clarithromycin; Erythromycin; Fibroblast Growth Factor 2; Gene Expression; Glucuronidase; Hepatocyte Growth Factor; Humans; Lung Neoplasms; Platelet-Derived Growth Factor; RNA, Messenger; Tumor Cells, Cultured | 2001 |
[Surgically resected lung cancer in patients complicated with diffuse interstitial pulmonary shadow].
Topics: Aged; Erythromycin; Female; Humans; Lung Diseases, Interstitial; Lung Neoplasms; Male; Methylprednisolone; Middle Aged; Perioperative Care; Pneumonectomy; Postoperative Complications; Prednisolone; Prognosis; Pulse Therapy, Drug; Smoking; Survival Rate | 2005 |
[New treatment not based on MIC for infectious diseases--making use of experience of macrolide long-term therapy].
Topics: Adult; Aged; Aged, 80 and over; Animals; Bronchiectasis; Bronchitis, Chronic; Clarithromycin; Erythromycin; Female; Humans; Lung Neoplasms; Macrolides; Male; Mice; Middle Aged | 2005 |
Nonresolving pneumonia in mycoplasma pneumoniae infection resembling a lung tumor.
Topics: Anti-Bacterial Agents; Biopsy; Diagnosis, Differential; DNA, Bacterial; Erythromycin; Female; Humans; Lung; Lung Neoplasms; Middle Aged; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Polymerase Chain Reaction | 2006 |
[The efficacy of perioperative administration of steroid and erythromycin in the surgery for lung cancer complicated with interstitial pneumonia].
Topics: Aged; Anti-Inflammatory Agents; Drug Therapy, Combination; Erythromycin; Female; Humans; Lung Diseases, Interstitial; Lung Neoplasms; Male; Methylprednisolone; Middle Aged; Perioperative Care; Pneumonectomy; Postoperative Complications | 2007 |
Emergence of multidrug-resistant Mycobacterium fortuitum during treatment.
Topics: Carcinoma, Squamous Cell; Cefoxitin; Drug Resistance, Microbial; Drug Therapy, Combination; Erythromycin; Humans; Lung Neoplasms; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Tuberculosis, Pulmonary | 1984 |
Levels of erythromycin in pulmonary tissue and bronchial mucus compared to those of amoxycillin.
Topics: Administration, Oral; Aged; Amoxicillin; Bronchi; Erythromycin; Female; Humans; Injections, Intravenous; Lung; Lung Neoplasms; Male; Middle Aged; Mucous Membrane | 1981 |
Bronchioloalveolar carcinoma with bronchorrhoea treated with erythromycin.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchi; Erythromycin; Humans; Lung Neoplasms; Male; Sputum | 1994 |
[Effect of clarithromycin in extending the life expectancy of patients with non-small-cell lung cancer].
Topics: Aged; Anti-Bacterial Agents; Carcinoma, Non-Small-Cell Lung; Clarithromycin; Erythromycin; Female; Humans; Immunologic Factors; In Vitro Techniques; Killer Cells, Lymphokine-Activated; Lung Neoplasms; Male; Survival Rate | 1997 |
Inhibitory effects of combined administration of antibiotics and anti-inflammatory drugs on lung tumor development initiated by N-nitrosobis(2-hydroxypropyl)amine in rats.
Topics: Adenocarcinoma; Ampicillin; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Bronchoalveolar Lavage Fluid; Carcinogens; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cocarcinogenesis; Disease Progression; Drug Evaluation, Preclinical; Drug Synergism; Drugs, Chinese Herbal; Erythromycin; Gene Expression Regulation; Inflammation; Lung Neoplasms; Macrophages; Male; Neutrophils; Nitrosamines; Penicillins; Piroxicam; Plant Extracts; Pneumonia, Bacterial; Rats; Rats, Sprague-Dawley; Scutellaria baicalensis; Specific Pathogen-Free Organisms | 2000 |
An autopsy case of diffuse panbronchiolitis associated with lung cancer.
Topics: Adenocarcinoma; Aged; Anti-Bacterial Agents; Autopsy; Bronchiolitis; Erythromycin; Female; Humans; Lung Neoplasms; Prognosis | 2000 |
Erythromycin and clarithromycin modulation of growth factor-induced expression of heparanase mRNA on human lung cancer cells in vitro.
Topics: Anti-Bacterial Agents; Cell Movement; Clarithromycin; Erythromycin; Fibroblast Growth Factor 2; Gene Expression; Glucuronidase; Hepatocyte Growth Factor; Humans; Immunologic Factors; Lung Neoplasms; Platelet-Derived Growth Factor; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured | 2001 |
[Respiratory tract diseases and infections].
Topics: Bronchitis; Chronic Disease; Erythromycin; Humans; Immune Tolerance; Lung Neoplasms; Opportunistic Infections; Respiratory Tract Diseases; Respiratory Tract Infections | 1991 |
Epidemiological screening for potentially carcinogenic drugs.
Topics: Barbiturates; Breast Neoplasms; Carcinogens; Diazepam; Dose-Response Relationship, Drug; Erythromycin; Folic Acid; Humans; Information Systems; Lung Neoplasms; Multiple Myeloma; Neoplasms; Product Surveillance, Postmarketing; Vitamin E | 1990 |
Screening prescription drugs for possible carcinogenicity: eleven to fifteen years of follow-up.
Topics: Anti-Bacterial Agents; Atropa belladonna; Carcinogens; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Esophageal Neoplasms; Folic Acid; Follow-Up Studies; Gastrointestinal Neoplasms; Lung Neoplasms; Lymphoma, Non-Hodgkin; Multiple Myeloma; Neomycin; Neoplasms; Phenylbutazone; Piperidones; Plants, Medicinal; Plants, Toxic; Polymyxin B; Propantheline; Secobarbital; Sulfathiazoles; Vitamins | 1989 |
[Short-term prophylaxis with erythromycin lactobionate in patients undergoing lung surgery].
Topics: Adult; Aged; Drug Evaluation; Erythromycin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Premedication; Random Allocation; Respiratory Function Tests; Time Factors | 1989 |